butyric acid and mart-1 antigen

butyric acid has been researched along with mart-1 antigen in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Cardoza, LM; Couture, LA; Kawakami, Y; Rosenberg, SA; Smith, AE; Spiess, P; Wadsworth, SC; Yang, JC; Zhai, Y	1

Other Studies

1 other study(ies) available for butyric acid and mart-1 antigen

Article	Year
Antigen-specific tumor vaccines. Development and characterization of recombinant adenoviruses encoding MART1 or gp100 for cancer therapy. Journal of immunology (Baltimore, Md. : 1950), 1996, Jan-15, Volume: 156, Issue:2 Topics: Adenoviridae; Adenovirus E3 Proteins; Animals; Antigens, Neoplasm; Butyrates; Butyric Acid; Cell Line; Defective Viruses; DNA, Recombinant; Gene Expression Regulation, Viral; Genetic Vectors; gp100 Melanoma Antigen; HLA-A2 Antigen; Humans; Immunodominant Epitopes; Immunotherapy, Active; Lymphocytes, Tumor-Infiltrating; MART-1 Antigen; Melanoma; Melanoma, Experimental; Membrane Glycoproteins; Mice; Mice, Inbred C57BL; Neoplasm Proteins; Neoplasm Transplantation; Recombinant Fusion Proteins; T-Lymphocytes, Cytotoxic; Tumor Necrosis Factor-alpha; Vaccination; Vaccines, Synthetic	1996

Article

Year

Antigen-specific tumor vaccines. Development and characterization of recombinant adenoviruses encoding MART1 or gp100 for cancer therapy.

Journal of immunology (Baltimore, Md. : 1950), 1996, Jan-15, Volume: 156, Issue:2

Topics: Adenoviridae; Adenovirus E3 Proteins; Animals; Antigens, Neoplasm; Butyrates; Butyric Acid; Cell Line; Defective Viruses; DNA, Recombinant; Gene Expression Regulation, Viral; Genetic Vectors; gp100 Melanoma Antigen; HLA-A2 Antigen; Humans; Immunodominant Epitopes; Immunotherapy, Active; Lymphocytes, Tumor-Infiltrating; MART-1 Antigen; Melanoma; Melanoma, Experimental; Membrane Glycoproteins; Mice; Mice, Inbred C57BL; Neoplasm Proteins; Neoplasm Transplantation; Recombinant Fusion Proteins; T-Lymphocytes, Cytotoxic; Tumor Necrosis Factor-alpha; Vaccination; Vaccines, Synthetic

1996